News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Long-term Dipyridamole Use and New Use of Low-dose Aspirin May Increase Risk for Subarachnoid Hemorrhage
July 6, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MedWire News: Long-term dipyridamole use and new use of low-dose aspirin may increase people's risk for subarachnoid hemorrhage (SAH), suggest findings from a population-based case-control study.
Twitter
LinkedIn
Facebook
Email
Print